• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素生物合成基因(CYP17)多态性与前列腺癌风险:一项荟萃分析。

Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.

机构信息

College of Public Health, Zhengzhou University, Zhengzhou, China.

School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.

出版信息

Am J Mens Health. 2020 Sep-Oct;14(5):1557988320959984. doi: 10.1177/1557988320959984.

DOI:10.1177/1557988320959984
PMID:32964792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7518003/
Abstract

Gene polymorphism is one of the few factors that increases the risk of prostate cancer. T to C substitution in the 5' promoter region of the CYP17 gene is hypothesized to increase the rate of gene transcription, increase androgen production, and thereby increase the risk of prostate cancer. Nevertheless, the inconsistencies originating from studies on CYP17 polymorphism and prostate cancer prompted this meta-analysis, to decipher the association between CYP17 polymorphism and prostate cancer. Most case-control studies addressing CYP17 polymorphism and prostate cancer were exhaustively searched from Web of Science, Google Scholar, and PubMed. The various genotype distributions as well as the minor allele distributions were retrieved. Pooled odds ratios (s) with their 95% CI and estimates of the Hardy-Weinberg Equilibrium were calculated. Analyses were performed using the RevMan v.5.3 software and SPSS v.21. There was high-pooled heterogeneity ( = 87.0%, = .42, CI [.39, .45], and < .001) among the A2 versus A1 allele. With the per-allele model (A2 versus A1), ethnicity was a major risk factor to prostate cancer, with Asians recording the highest risk ( = 12.61, 95% CI [8.77, 18.12]). From the genotype models, A1/A1 versus A2/A2 ( = 3.02, 95% CI [2.65, 3.44]) and A1/A2 versus A2/A2 ( = 4.39, 95% CI [3.86, 5.00]) were all significantly associated with prostate cancer. Although some genotype models were associated with the risk of prostate cancer, we should be mindful when interpreting the results of this study because of the limited number of studies and the small sample size used.

摘要

基因多态性是增加前列腺癌风险的少数因素之一。CYP17 基因 5'启动子区域的 T 到 C 替换被假设可以增加基因转录率,增加雄激素的产生,从而增加前列腺癌的风险。然而,由于 CYP17 多态性与前列腺癌的研究结果不一致,促使进行了这项荟萃分析,以阐明 CYP17 多态性与前列腺癌之间的关联。从 Web of Science、Google Scholar 和 PubMed 中全面搜索了关于 CYP17 多态性和前列腺癌的病例对照研究。检索了各种基因型分布和次要等位基因分布。计算了合并优势比(OR)及其 95%置信区间(CI)和 Hardy-Weinberg 平衡估计值。使用 RevMan v.5.3 软件和 SPSS v.21 进行分析。A2 与 A1 等位基因之间存在高度合并的异质性( = 87.0%, =.42,CI [.39,.45], <.001)。在等位基因模型中(A2 与 A1),种族是前列腺癌的一个主要危险因素,亚洲人记录的风险最高( = 12.61,95%CI [8.77,18.12])。从基因型模型来看,A1/A1 与 A2/A2( = 3.02,95%CI [2.65,3.44])和 A1/A2 与 A2/A2( = 4.39,95%CI [3.86,5.00])均与前列腺癌显著相关。尽管某些基因型模型与前列腺癌的风险相关,但由于研究数量有限且使用的样本量较小,在解释研究结果时应保持谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/6268f8b9a78e/10.1177_1557988320959984-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/42682eef5e76/10.1177_1557988320959984-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/80af2e5f17ea/10.1177_1557988320959984-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/46e60f1adb3f/10.1177_1557988320959984-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/77459784f616/10.1177_1557988320959984-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/0af0ae5e2bf7/10.1177_1557988320959984-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/6268f8b9a78e/10.1177_1557988320959984-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/42682eef5e76/10.1177_1557988320959984-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/80af2e5f17ea/10.1177_1557988320959984-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/46e60f1adb3f/10.1177_1557988320959984-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/77459784f616/10.1177_1557988320959984-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/0af0ae5e2bf7/10.1177_1557988320959984-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402f/7518003/6268f8b9a78e/10.1177_1557988320959984-fig6.jpg

相似文献

1
Polymorphism in the Androgen Biosynthesis Gene (CYP17), a Risk for Prostate Cancer: A Meta-Analysis.雄激素生物合成基因(CYP17)多态性与前列腺癌风险:一项荟萃分析。
Am J Mens Health. 2020 Sep-Oct;14(5):1557988320959984. doi: 10.1177/1557988320959984.
2
Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.一种具有基因剂量效应的CYP17基因多态性与前列腺癌和良性前列腺增生风险增加相关。
Cancer Res. 2000 Oct 15;60(20):5710-3.
3
Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.CYP17 Mspa1 多态性与前列腺癌风险之间缺乏关联:14494 例病例和 15971 例对照的荟萃分析。
Medicina (Kaunas). 2013;49(2):51-5.
4
A polymorphism in the CYP17 gene and risk of prostate cancer.细胞色素P450 17α羟化酶/17,20裂解酶(CYP17)基因多态性与前列腺癌风险
Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):243-7.
5
A polymorphism in the CYP17 gene is associated with prostate cancer risk.细胞色素P450 17α羟化酶/17,20裂解酶(CYP17)基因的多态性与前列腺癌风险相关。
Int J Cancer. 2000 Aug 1;87(3):434-7. doi: 10.1002/1097-0215(20000801)87:3<434::aid-ijc19>3.0.co;2-g.
6
CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.细胞色素P450 17(CYP17)基因多态性与前列腺癌和良性前列腺增生风险的关系:一项基于中国人群的研究。
Int J Cancer. 2003 Nov 1;107(2):271-5. doi: 10.1002/ijc.11378.
7
The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.细胞色素P450 17α羟化酶(CYP17)基因多态性与血浆激素水平及前列腺癌之间的关系。
Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):743-8.
8
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).17α-羟化酶(CYP17)和类固醇5α-还原酶2(SRD5A2)基因多态性与前列腺癌风险
Carcinogenesis. 1999 Sep;20(9):1727-31. doi: 10.1093/carcin/20.9.1727.
9
Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.CYP17基因多态性与前列腺癌风险的关联:一项荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):120-6.
10
Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.17-羟化酶细胞色素P-450(CYP17)和II型类固醇5α-还原酶(SRD5A2)基因多态性对日本人群前列腺癌风险的影响。
Int J Cancer. 2001 Jun 1;92(5):683-6. doi: 10.1002/1097-0215(20010601)92:5<683::aid-ijc1255>3.0.co;2-4.

引用本文的文献

1
A Review on , , and Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.多囊卵巢综合征(PCOS)与不孕相关的 、 及 多态性研究综述:候选易感基因
Genes (Basel). 2022 Feb 5;13(2):302. doi: 10.3390/genes13020302.

本文引用的文献

1
The role of nutrition related genes and nutrigenetics in understanding the pathogenesis of cancer.营养相关基因和营养遗传学在理解癌症发病机制中的作用。
J Microsc Ultrastruct. 2016 Jul-Sep;4(3):115-122. doi: 10.1016/j.jmau.2016.02.002. Epub 2016 Mar 8.
2
Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry.雌激素代谢相关基因多态性与两个非洲裔人群的前列腺癌风险
PLoS One. 2016 Apr 13;11(4):e0153609. doi: 10.1371/journal.pone.0153609. eCollection 2016.
3
Association of CYP1A1, CYP1B1 and CYP17 gene polymorphisms and organochlorine pesticides with benign prostatic hyperplasia.
CYP1A1、CYP1B1 和 CYP17 基因多态性与有机氯农药与良性前列腺增生的关联。
Chemosphere. 2014 Aug;108:40-5. doi: 10.1016/j.chemosphere.2014.02.081. Epub 2014 Apr 9.
4
Association of benign prostate hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men.黎巴嫩男性中良性前列腺增生与维生素D受体(VDR)、细胞色素P450 17α羟化酶(CYP17)和5α还原酶2(SRD5A2)基因多态性的关联。
Asian Pac J Cancer Prev. 2014;15(3):1255-62. doi: 10.7314/apjcp.2014.15.3.1255.
5
Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression.甘醇醛酶 1-419C>A 变体与氧化应激相关:在前列腺癌进展中的意义。
PLoS One. 2013 Sep 10;8(9):e74014. doi: 10.1371/journal.pone.0074014. eCollection 2013.
6
CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.CYP17 基因多态性与前列腺癌风险:基于 38 项独立研究的荟萃分析。
Prostate. 2011 Aug 1;71(11):1167-77. doi: 10.1002/pros.21332. Epub 2011 Jan 12.
7
Review of studies on metabolic genes and cancer in populations of African descent.非洲裔人群代谢基因与癌症相关研究述评
Genet Med. 2010 Jan;12(1):12-8. doi: 10.1097/GIM.0b013e3181c8e160.
8
Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.对12个类固醇激素代谢基因变异与前列腺癌风险之间关联的单基因和多基因分析。
Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1869-80. doi: 10.1158/1055-9965.EPI-09-0076.
9
Role of hormonal genes and risk of prostate cancer: gene-gene interactions in a North Indian population.激素基因的作用与前列腺癌风险:北印度人群中的基因-基因相互作用
Cancer Genet Cytogenet. 2008 Sep;185(2):78-85. doi: 10.1016/j.cancergencyto.2008.04.022.
10
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.CYP17选择性抑制剂醋酸阿比特龙的I期临床试验证实,去势抵抗性前列腺癌通常仍由激素驱动。
J Clin Oncol. 2008 Oct 1;26(28):4563-71. doi: 10.1200/JCO.2007.15.9749. Epub 2008 Jul 21.